These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26230881)

  • 1. Inosine 5'-monophosphate dehydrogenase inhibitors as antimicrobial agents: recent progress and future perspectives.
    Shah CP; Kharkar PS
    Future Med Chem; 2015; 7(11):1415-29. PubMed ID: 26230881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors.
    Hedstrom L; Liechti G; Goldberg JB; Gollapalli DR
    Curr Med Chem; 2011; 18(13):1909-18. PubMed ID: 21517780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
    Nair V; Shu Q
    Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.
    Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A
    J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inosine 5'-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases.
    Ratcliffe AJ
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):595-605. PubMed ID: 17002220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inosine monophosphate dehydrogenase as a target for antiviral, anticancer, antimicrobial and immunosuppressive therapeutics.
    Braun-Sand SB; Peetz M
    Future Med Chem; 2010 Jan; 2(1):81-92. PubMed ID: 21426047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel inhibitors of inosine monophosphate dehydrogenase in patent literature of the last decade.
    Petrelli R; Vita P; Torquati I; Felczak K; Wilson DJ; Franchetti P; Cappellacci L
    Recent Pat Anticancer Drug Discov; 2013 May; 8(2):103-25. PubMed ID: 23016672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors: a patent and scientific literature review (2002-2016).
    Cuny GD; Suebsuwong C; Ray SS
    Expert Opin Ther Pat; 2017 Jun; 27(6):677-690. PubMed ID: 28074661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inosine 5'-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents.
    Fotie J
    Mini Rev Med Chem; 2018; 18(8):656-671. PubMed ID: 27334467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The determination and clinical application of inosine 5’-monophosphate dehydrogenase activity].
    Liu FY; Qiu XY; Jiao Z
    Yao Xue Xue Bao; 2016 Nov; 51(11):1666-73. PubMed ID: 29908108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The basic functions of inosine 5'-monophosphate dehydrogenase and its application in drug discovery].
    Zhang YW; Zhang D; Sun H
    Yao Xue Xue Bao; 2014 Mar; 49(3):285-92. PubMed ID: 24961097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
    Shah CP; Kharkar PS
    Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of the inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
    Cholewiński G; Iwaszkiewicz-Grześ D; Prejs M; Głowacka A; Dzierzbicka K
    J Enzyme Inhib Med Chem; 2015; 30(4):550-63. PubMed ID: 25198892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent "fat base" nucleotide inhibitor of IMP dehydrogenase.
    Wang W; Hedstrom L
    Biochemistry; 1998 Aug; 37(34):11949-52. PubMed ID: 9718319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors.
    Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis.
    Trapero A; Pacitto A; Singh V; Sabbah M; Coyne AG; Mizrahi V; Blundell TL; Ascher DB; Abell C
    J Med Chem; 2018 Apr; 61(7):2806-2822. PubMed ID: 29547284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
    Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
    Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of curcumin on IMP dehydrogenase, the target for anticancer and antiviral chemotherapy agents.
    Dairaku I; Han Y; Yanaka N; Kato N
    Biosci Biotechnol Biochem; 2010; 74(1):185-7. PubMed ID: 20057137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-dimensional pharmacophore model for IMPDH inhibitors.
    Yang N; Wang J; Li J; Wang QH; Wang Y; Cheng MS
    Chem Biol Drug Des; 2011 Jul; 78(1):175-82. PubMed ID: 21507206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of novel inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
    Dunkern T; Chavan S; Bankar D; Patil A; Kulkarni P; Kharkar PS; Prabhu A; Goebel H; Rolser E; Burckhard-Boer W; Arumugam P; Makhija MT
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):408-19. PubMed ID: 23663081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.